Position in EVGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,598
-$3,404 QoQ
Shares Held
12,465
+9.3% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EVGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA SECURITIES, LLC holds $22,483,013 across 103 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,761 | $3,592,213 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,585 | $1,681,252 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
17,689 | $1,317,476 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,219 | $1,191,492 | |
| 5 | INSM |
INSMED Inc
|
10,338 | $1,102,237 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
12,525 | $980,331 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
11,256 | $917,476 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
3,708 | $907,607 |
All Filings in EVGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,598 | 12,465 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $13,002 | 11,406 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $26,993 | 21,089 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,952 | 13,562 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,867 | 11,159 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $8,544 | 13,145 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $10,393 | 12,373 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,668 | 14,692 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,725 | 10,958 | Shares | Sole | 2023-08-14 | |
| 2022-06-30 | $7,891 | 10,249 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||